Cisplatin Injection, Solution
Product Images NDC 60505-6279

This is a description of Cisplatin, a cytotoxic agent used for intravenous use in the treatment of cancer. The medication is provided in a sterile solution containing cisplatin and sodium chloride. It is typically administered once every 3 to 4 weeks, with dosages rarely exceeding 100 mg/m². The accompanying insert contains detailed information on indications, dosage, directions for use, and precautions. It is important to store the medication at room temperature and protect it from light. The manufacturer is QILU Pharmaceutical Co., Ltd. in China, and the medication is distributed by Apotex Corp. in the USA.*

This text appears to be a label or information sheet for the drug Cisplatin, an anti-cancer medication used for intravenous administration. It contains details about the drug name, dosage, storage instructions, manufacturer information, and a caution about cytotoxic properties. The document emphasizes the importance of reading the enclosed insert for detailed indications, dosage, directions for use, and precautions. It also mentions that Cisplatin doses greater than 100 mg every 3-4 weeks are rarely used and advises not to refrigerate the medication. The text provides specific storage conditions, such as storing at controlled room temperature and protecting it from light. It also includes information about the sterile solution for intravenous use and the manufacturer's details.*

This document provides detailed instructions for the proper handling and labeling of Clisplatin injections. It outlines the process of adhering safety stickers to the drug container and how pharmacists should record the total dose of the medication. The stickers are meant to track the medication from the pharmacy to administration to the patient, ensuring accurate dosing and safe medication practices. These safety measures can help prevent errors and improve patient care.*